Researchers Say PDE5 Inhibitors Don't Cause Melanoma

Share this content:
Researchers Say PDE5 Inhibitors Don't Cause Melanoma
Researchers Say PDE5 Inhibitors Don't Cause Melanoma

FRIDAY, May 19, 2017 (HealthDay News) -- Use of phosphodiesterase type 5 (PDE5) inhibitors does not appear to increase the risk of melanoma, according to the conclusions of a meta-analysis published online May 19 in the Journal of the National Cancer Institute.

Stacy Loeb, M.D., a urologist and assistant professor at the NYU Langone Medical Center in New York City, and colleagues analyzed data from five large-scale studies of 866,049 men who used PDE5 inhibitors.

While users had an overall 11 percent increased risk of melanoma, there wasn't evidence that the drugs cause melanoma. The link appears due to detection bias, the researchers said in an NYU news release, as men likely to take erectile medications tend to be more health-conscious, more likely to see a doctor, and therefore more likely to get diagnosed with melanoma than other men of similar age.

"Physicians should still screen for melanoma risk, but they do not need to add the use of Viagra and similar drugs to the list of screening criteria specifically," Loeb said in the news release.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

High Success Rates for Mitral Valve Repair With Robotic Surgery

High Success Rates for Mitral Valve Repair With ...

Minimally invasive surgery linked to fewer discharges to facility, one day less in hospital vs conservative sx

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Inflammatory myopathy identified in woman with cystic fibrosis on long-term immunosuppressants

Rates of Cardiac Stress Testing Down but Still Higher in CKD

Rates of Cardiac Stress Testing Down but Still ...

Decline in rates of cardiac stress testing in Medicare beneficiaries aged ≥66 years from 2008 to 2012

is free, fast, and customized just for you!




Already a member?

Sign In Now »